Twist Bioscience Corporation (TWST) Balance Sheet
As of 2026-06-30 (10-Q), Twist Bioscience Corporation (TWST) reported total assets of $672.4M, total liabilities of $226.7M and shareholders' equity of $445.7M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $117.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TWSTTwist Bioscience CorporationFollow TWST — free
—
Price chart with a free account
- Market cap
- 8.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 13 Nov, in 20 days
| Line | FY2019 Sep 19 | FY2020 Sep 20 | FY2021 Sep 21 | FY2022 Sep 22 | FY2023 Sep 23 | FY2024 Sep 24 | FY2025 Sep 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 46.7 | 93.7 | 465.8 | 378.7 | 286.5 | 226.3 | 183.0 | 117.4 | |
| Short-term investments | 91.4 | 196.3 | 12.0 | 126.3 | 49.9 | 50.1 | 49.4 | 49.4 | |
| Receivables | 12.1 | 26.4 | 28.5 | 40.3 | 44.1 | 34.9 | 57.0 | 65.1 | |
| Inventory | 7.3 | 12.3 | 31.8 | 39.3 | 32.1 | 24.1 | 28.3 | 35.2 | |
| Current assets | 160.1 | 334.9 | 546.5 | 596.5 | 424.3 | 346.8 | 333.0 | 321.3 | |
| Total assets | 187.0 | 398.9 | 702.1 | 961.4 | 776.4 | 614.3 | 641.9 | 672.4 | |
| Current liabilities | 30.4 | 36.0 | 63.1 | 90.7 | 73.3 | 71.0 | 91.4 | 120.3 | |
| Long-term debt | 4.4 | 1.4 | — | — | — | — | — | — | |
| Short-term debt | 3.3 | 3.3 | 1.6 | 0.0 | — | — | — | — | |
| Total liabilities | 34.9 | 62.6 | 121.3 | 172.0 | 153.0 | 141.6 | 168.9 | 226.7 | |
| Shareholders' equity | 152.1 | 336.3 | 580.8 | 789.4 | 623.4 | 472.7 | 473.0 | 445.7 |
USD millions · SEC XBRL
Twist Bioscience Corporation — questions
- How much cash does Twist Bioscience Corporation have?
- $117.4M in cash and cash equivalents as of 2026-06-30.
- What are Twist Bioscience Corporation's total assets?
- $672.4M as of 2026-06-30.
- What is Twist Bioscience Corporation's shareholders' equity?
- $445.7M as of 2026-06-30.
Every figure on this page comes from Twist Bioscience Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.